Company

Hypera SA

Headquarters: Sao Paulo, SP, Brazil

Employees: 9,000

Bovespa: HYPE3 -2.05%

Market Cap

R$18.30 Billion

BRL as of July 1, 2024

US$3.23 Billion

Market Cap History

Hypera SA market capitalization over time

Evolution of Hypera SA market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Hypera SA

Detailed Description

Hypera S.A. operates as a pharmaceutical company in Brazil. It offers branded prescription products under the Mantecorp Farmasa, Episol, Predsim, Alivium, Lisador, Rinosoro, Celestamine, Maxsulid, Diprospan, Mioflex-A, and Addera D3 brands; dermo-cosmetics products under the Mantecorp Skincare brands; and consumer health products under the Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, and other brands. The company also provides nutrition, sweeteners, and vitamin supplement products under the Tamarine, Vitasay 50+, Biotônico Fontoura, and Zero-Cal brands; and similar and generic medicines under the Neo Química, Torsilax, Neosoro, Doralgina, Flavonid, and Histamin brands. It sells its products through distributors and wholesalers. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. was founded in 2001 and is headquartered in São Paulo, Brazil.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Hypera SA has the following listings and related stock indices.


Stock: Bovespa: HYPE3 wb_incandescent

Stock: XSTU: HM6A wb_incandescent

Stock: OTC: HYPMY wb_incandescent

Details

Headquarters:

Av. MagalhAes de Castro, 4800

24th floor, Suite 241 EdifIcio Continental Tower Bairro Cidade Jardim

Sao Paulo, SP 05676-120

Brazil

Phone: 55 11 3627 4206

Fax: 55 11 3627 4371